This change causes M2 macrophages to become more polarized, which in turn creates an immunosuppressive tumor microenvironment that reduces the effectiveness of ICIs such as PD-1/PD-L1 and CTLA-4 blockers [68]. Here, CTLA4 is linked to neoplasm.